Fig. 5From: Network pharmacology-based study on the mechanism of Yiganling capsule in hepatitis B treatmenta YGL capsule-HB disease network that only includes disease targets (red circles represent compounds that directly affect HB targets, purple circles represent compound with an indirect role in HB targets). b Clusters of the YGL compound-HB network (a-h represent clusters 1–8)Back to article page